{
    "accession": "ENCBS328CYG", 
    "age": "50", 
    "age_units": "year", 
    "applied_modifications": [
        {
            "category": "interference", 
            "method": "RNAi", 
            "modified_site_by_target_id": "ZFX", 
            "purpose": "repression", 
            "reagents": [
                {
                    "identifier": "L-006572-00-0005", 
                    "source": "/sources/dharmacon/", 
                    "url": "http://dharmacon.gelifesciences.com/sirna/on-targetplus-sirna-reagents-human/?productId=0A5D2392-CB32-4170-B4F1-659C6944E4B9"
                }
            ]
        }
    ], 
    "biosample_term_id": "EFO:0006365", 
    "biosample_term_name": "C4-2B", 
    "biosample_type": "cell line", 
    "characterizations": [], 
    "dbxrefs": [
        "Cellosaurus:CVCL_4784"
    ], 
    "description": "C4-2B cells treated with a siRNA knockdown against ZFX, used in RNA-seq experiments.", 
    "documents": [
        {
            "attachment": "/documents/5b73565c-318c-4f72-b997-0ce36ecf7127/@@download/attachment/basic-sirna-resuspension-protocol.pdf", 
            "document_type": "other", 
            "references": [], 
            "urls": []
        }, 
        {
            "attachment": "/documents/c08a4007-fe0e-4617-96eb-34817ea2bb73/@@download/attachment/basic-dharmafect-protocol.pdf", 
            "document_type": "transfection protocol", 
            "references": [], 
            "urls": []
        }
    ], 
    "donor": "ENCDO000ACX", 
    "health_status": "prostate adenocarcinoma", 
    "lab": "Peggy Farnham, USC", 
    "life_stage": "adult", 
    "organism": "Homo sapiens", 
    "references": [], 
    "sex": "male", 
    "source": "ViroMed Laboratories", 
    "summary": "Homo sapiens C4-2B cell line expressing RNAi targeting ZFX", 
    "treatments": []
}